Company Profile

BioProtect developed a proprietary technology platform for biodegradable balloons. The technology suits a wide range of clinical applications, radiation oncology spacing, aesthetics and general surgery.

The company’s first application in the commercialization stage is the ProSpaceTM Balloon System acting as a spacer for the protection of healthy tissue in patients receiving radiotherapy for prostate cancer

The product is commercially available in Europe, and is undergoing clinical studies in the USA prior to FDA regulatory approval.
BioProtect has a robust product pipeline, developed in consultation with leading physicians regarding unmet radiotherapy spacing and other clinical needs.

 

 

about us
Investor contact info

Shahar Shaked, CFO
Shahar@bioprotect.com
bioprotect.com